Nanopharmaceutical Drugs Market Projected to Witness a Double-Digit CAGR During 2020 – 2027

Market Size – USD 46.90 Billion in 2019, Market Growth – CAGR of 7.3%, Market Trends –Technological advancements in disease diagnostic procedures

VANCOUVER, BC, CANADA, June 16, 2022 /EINPresswire.com/ — The global nanopharmaceutical drugs market is projected to be worth USD 82.71 Billion by 2027, according to a current analysis by Emergen Research. The nanopharmaceutical drugs market is observing high demand attributed to the rising incidence of cancer. Cancer significantly impacts the societal and economic growth in the US and worldwide and is a major contributor to the cost burden of disease. It has been anticipated that 1,806,590 new cancer cases are likely to be diagnosed in the US in 2020, and 606,520 deaths will occur owing to the disease. The advantages offered by nanopharmaceutical drugs comprise targeting lesions/tumor cells, apoptosis commencement, and drug accumulation in specific tissue for improved cancer cells’ exposure cells. Existing pharmaceuticals formulation into the nanoscale has resulted in lower toxicity levels and better cell specificity.

The nanopharmaceutical drugs have been garnering significant market traction due to the ability of such drug systems to overcome restrictions and issues associated with conventional pharmaceutical agents, preparations, and delivery systems. 

The latest and updated research report on the Global Nanopharmaceutical Drugs Market covers a comprehensive overview of the Nanopharmaceutical Drugs market, future economic condition, competitive landscape mapping, supply and demand trends, and production and consumption analysis. The report also covers the influence of the COVID-19 pandemic on the Nanopharmaceutical Drugs market. The pandemic has dynamically affected all aspects of life on a global scale along with drastic changes in the economy and market conditions. The report covers the currently fluctuating market scenario along with present and future assessment of the COVID-19 impact. The report encompasses the historical data, company overview, financial standing, and necessary information about the new and key players of the market.

Get a sample of the report @ 

Some Key Highlights from the Report
In February 2019, Sanofi entered into a definitive agreement with NH TherAGuIX for the introduction of AGuIX^® Nanoparticle in the field of cancer treatment. This agreement offers NH TherAGuIX the benefit to gain from the experience and industrial expertise of Sanofi in producing active pharmaceutical ingredients (API).

Microemulsion formulations are considered to be advantageous compared to conventional oral formulations and provide improved absorption, increased clinical potency, and decreased drug toxicity.

The application of nanotechnologies has extremely transformed the pharmaceutical and biotechnology sector landscape, with nearly 100 nanomedicine products at present being sanctioned for clinical use varying from drug delivery to and medical devices.

Nanopharmaceutical drugs for antimicrobial drug delivery provide unique benefits in reducing resistance and triggering fewer side effects compared to conventional antibiotics. Nanopharmaceutical drugs can induce efficient immune responses compared to microbial infection.

The market in the North American region held the largest market share in 2019, owing to high adoption of advanced diagnostic procedures, a rising incidence of chronic conditions, established healthcare infrastructure, and undertaking of various initiatives to create awareness about the disease.

The report offers a comprehensive overview of the competitive landscape and covers company profiles, production and manufacturing capacity, product portfolio, expansion strategies, and business initiatives such as mergers and acquisitions, joint ventures, collaborations, partnerships, and product launches and brand promotions among others.

Prominent Players Analyzed in the Report:

Amgen Inc., AstraZeneca PLC, Gilead Sciences Inc., Novartis AG, F. Hoffmann-La Roche AG, AbbVie Inc., Johnson & Johnson, Pfizer Inc., Sanofi SA, and Merck & Co. Inc., among others.

Request a discount on the report @

Furthermore, the report divides the Nanopharmaceutical Drugs market into key segments and sub-segments to offer an analysis of the product type and application spectrum of the industry. It also offers predictions about the segments expected to show significant growth during the projected timeline.

Emergen Research has segmented the global nanopharmaceutical drugs market on the basis of type, application, distribution channel, and region:

Type Outlook (Revenue, USD Billion; 2017-2027)
Liposomes

Polymeric Micelles

Microemulsion

Solid Lipid Nanoparticles

Nanoemulsion

Others

Application Outlook (Revenue, USD Billion; 2017-2027)
Oncology

Cardiovascular/Physiology

Anti-inflammatory/Immunology

Neurology

Anti-Infective

Others

Distribution Channel Outlook (Revenue, USD Billion; 2017-2027)
Hospital Pharmacies

Retail Off-Line Pharmacies

Retail On-Line Pharmacies

The report offers a comprehensive breakdown of the regional analysis of the market and subsequent country-wise analysis. The regional analysis of the market comprises of production volume information, consumption volume and patterns, revenue, and growth rate for the forecast period of 2020-2027. According to the regional analysis, the market is primarily spread over key geographical regions as follows:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Request customization of the report @

The report covers key points of the market, including the standards, regulations, and policy changes applied by the government on the industry for the coming years. The report encompasses thorough research carried out by the application of advanced analytical tools such as SWOT analysis and Porter’s Five Forces analysis to pinpoint the growth trends and patterns. Factors likely to influence the growth of the market, current trends, opportunities, restraining factors, and business landscape are discussed in-depth in the market study.

Overview of the Nanopharmaceutical Drugs Market Report:

Introduction, Product Scope, Market Overview, and Opportunities

Analysis of the Manufacturers with sales, revenue, and price analysis

Comprehensive analysis of the competitive landscape

Extensive profiling of the key competitors along with their business strategies and market size

Regional analysis of the market along with sales, revenue, market share, and global position

Country-wise analysis of the market along with types, applications, and manufacturing

Strategic recommendations to established players as well as new entrants

In-depth analysis of the risks, restraints, and limitations in the Nanopharmaceutical Drugs industry

Click here to Buy Now @

Thank you for reading our report. Please connect with us to know more about the report or the customization of the report. Our team will ensure the report is best suited to meet your requirements.

Read similar reports by Emergen Research:

Digital Water Market

Fluid Transfer System Market

E-Waste And Information Technology Asset Disposition Market

Fc Fusion Protein Market

Ai-Enabled Medical Imaging Solutions Market

Push To Talk Market

Hunting And Shooting Ammunition Market

Occlusion Devices Market

Sports Technology Market

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Eric Lee
Emergen Research
+91 90210 91709
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn

Nanopharmaceutical Drugs Market Size Worth USD 82.71 Billion by 2027